| Literature DB >> 32651708 |
Sascha Marx1, Ioanna Tsavdaridou2, Sebastian Paul2,3, Antje Steveling4, Cornelia Schirmer4, Marton Eördögh5, Stephan Nowak5, Marc Matthes5, Ehab El Refaee5,6, Steffen K Fleck5, Joerg Baldauf5, Markus M Lerch4, Andreas Stahl3, Werner Hosemann2, Henry W S Schroeder5.
Abstract
The endoscopic endonasal approach to suprasellar craniopharyngiomas has become popular as alternative to transcranial approaches. However, the literature lacks data regarding quality of life and olfactory function. The assessment of the long-term quality of life and olfactory function of all patients harboring a suprasellar craniopharyngioma who underwent surgery in our department has been done. Patient characteristics and perioperative data were gathered in a prospectively maintained database. At the last follow-up visit, the olfactory function and the quality of life (ASBQ, SNOT-22) as well as visual and pituitary function were assessed. Thirteen and 17 patients underwent surgery via a transcranial (T) and endonasal (E) route, respectively. No differences were seen in ASBQ, SNOT-22, and olfactory function between T and E, but in E were more full-time worker and less obesity. CSF leaks occurred in 15% of T and 29% of E (p = 0.43). Patients from group E had a superior visual outcome which was most pronounced in the visual field. The degree of new anterior and posterior pituitary gland deficiency after surgery and in the follow-up was lower in group E. The general and sinonasal quality of life and the olfactory function are equal in E and T. E is associated with a superior visual outcome, lower rates of diabetes insipidus, and lower rates of obesity, but has a higher risk for postoperative CSF leaks.Entities:
Keywords: Craniopharyngioma; Endonasal approach; Long-term follow-up; Olfactory function; Quality of life; Skull base tumors; Transcranial approach
Mesh:
Year: 2020 PMID: 32651708 PMCID: PMC8121742 DOI: 10.1007/s10143-020-01343-x
Source DB: PubMed Journal: Neurosurg Rev ISSN: 0344-5607 Impact factor: 3.042
Fig. 1The 7-year-old boy presented with signs of hypopituitarism such as loss of weight, arrest of growth, impairment of his general condition, and fatigue. Since 4 weeks he had been complaining about headache and vomiting. The endocrinological evaluation demonstrated panhypopituitarism, but no obvious DI. a–c MR imaging revealed an intra-suprasellar circumferentially contrast enhancing cystic lesion which was highly suspicious of a craniopharyngioma. d The tumor (T) was approached in the interoptic window via a right-sided frontolateral approach exposing the right optic nerve (ON). e The tumor capsule was incised with a knife. f Calcified tumor parts were removed with tumor forceps. g The tumor was dissected using the bimanual traction-countertraction technique with two forceps. h Intrasellar tumor parts (T) which could not be visualized with the microscope were removed under endoscopic view of a 30° endoscope. i The final inspection showed the gross total tumor resection and intact optic nerves (ON). j–l MR imaging obtained 2 years after surgery showed no recurrence. The boy is doing well under full hormonal replacement therapy
Fig. 2The 84-year-old lady presented with visual problems. The ophthalmological examination revealed a bilateral loss of visual acuity and bitemporal visual field deficits. The endocrinological evaluation demonstrated an intact pituitary function. a–c MR imaging revealed a suprasellar partially solid, partially cystic contrast enhancing lesion which was highly suspicious of a craniopharyngioma. d A transtuberculum-transplanum approach was performed. The protuberances of the optic nerves (ON), clinoidal carotid arteries (C), and sellar dura (S) are seen. e After debulking of the tumor, the superior surface of the tumor was exposed under view of a 30° endoscope. The A2 segment of the right anterior cerebral artery and the right optic nerve (ON) are seen. f The tumor was dissected from the optic chiasm using the bimanual traction-countertraction technique with two forceps (optic nerve (ON), A1- and A2-segments of the anterior cerebral arteries (A1, A2). g At the dorsal tumor surface, the infiltrated pituitary stalk (ST, in between the dashed line) is visualized. Oculomotor (O), P1-segment of the posterior cerebral artery (P), and posterior communicating artery (arrowhead) are seen. h After tumor resection severe grooving (arrows) within the left optic nerve caused by the tumor pressure against the nerve and the A1-segment of the anterior cerebral artery (A1 und A2) is seen. i The final inspection shows the tumor remnant (T) at the infiltrated pituitary stalk (ST), the posterior communicating artery (arrow head), the supraclinoidal carotid artery (C), and the oculomotor nerve (O). j–l MR imaging obtained 3 months after surgery showed the tumor residual at the pituitary stalk. m–o MR imaging obtained 22 months after fractionated stereotactic radiotherapy with 45 Gy revealed an impressive shrinking of the tumor. The patient is doing well under replacement therapy of hydrocortisone and thyroxine. The ophthalmological examination revealed a marked improvement of the visual field deficits
Characteristics of patients with a transcranial or endonasal approach to suprasellar craniopharyngiomas. p ≤ 0.05 is considered statistically significant. NS nonsignificant
| Total | Group transcranial | Group endonasal | |||||
|---|---|---|---|---|---|---|---|
| % | % | ||||||
| No. of patients | 30 | 13 | 43 | 17 | 57 | ||
| Age (years) | Mean | 41 | 31.2 | 48.5 | 0.04 | ||
| Range | (1 … 84) | (1 … 61) | (12 … 84) | ||||
| Female | 16 | 8 | 62 | 8 | 47 | NS | |
| Male | 14 | 5 | 38 | 9 | 53 | NS | |
| Pediatric patients | 4 | 3 | 23 | 1 | 6 | NS | |
| Initial diagnosis | 28 | 12 | 92 | 16 | 94 | NS | |
| Follow-up | Mean (months) | 136 | 56 | 0.002 | |||
| Range | (34 … 202) | (12 … 145) | |||||
| Lost-to | 6 | 3 | 23 | 3 | 18 | NS | |
| Repeat surgery | Total | 4 | 2 | 15 | 2 | 12 | NS |
| Transcranial | 4 | 2 | 2 | ||||
| Endonasal | 0 | 0 | 0 | ||||
| Adjuvant radiation | All indications | 8 | 2 | 15 | 6 | 35.3 | NS |
| After STR | 5 | 1 | 4 | ||||
| Tumor recurrence | 3 | 1 | 2 | ||||
Surgical characteristics of patients with a transcranial or endonasal approach to suprasellar craniopharyngiomas. p ≤ 0.05 is considered statistically significant. NS nonsignificant, EOR extent of resection, GTR gross total resection, STR subtotal resection, CSF cerebrospinal fluid
| Total | Group transcranial | Group endonasal | |||||
|---|---|---|---|---|---|---|---|
| % | % | ||||||
| EOR | GTR | 17 | 7 | 54 | 10 | 59 | NS |
| STR | 8 | 5 | 38 | 3 | 18 | NS | |
| Partial | 5 | 1 | 8 | 4 | 23 | NS | |
| Stalk preservation | 18 | 5 | 39 | 13 | 76 | 0.06 | |
| Complications | All | 17 | 5 | 39 | 11 | 65 | 0.14 |
| CSF leak | 7 | 2 | 15 | 5 | 29 | NS | |
| Perioperative death | 1 | 1 | 8 | 0 | 0 | NS | |
| Meningitis | 2 | 0 | 0 | 2 | 12 | NS | |
| Hydrocephalus | 2 | 0 | 0 | 2 | 12 | NS | |
| Other | 4 | 2 | 15 | 2 | 12 | NS | |
Visual outcome of patients with a transcranial or endonasal approach to suprasellar craniopharyngiomas. p ≤ 0.05 is considered statistically significant. NS nonsignificant
| Group transcranial | Group endonasal | |||||
|---|---|---|---|---|---|---|
| % | % | |||||
| Visual acuity | ||||||
| Pre-OP | Impairment (eyes) | 11 | 42 | 11 | 39 | NS |
| logMAR left eye | 0.1 | 0.1 | NS | |||
| logMAR right eye | 0.1 | 0.2 | NS | |||
| Post-OP | Improved to pre-OP | 5 | 45 | 10 | 91 | 0.02 |
| Deteriorated to pre-OP | 0 | 0 | 1 | 9 | NS | |
| Lost to follow-up | 2 | 8 | 0 | 0 | NS | |
| logMAR left eye | 0.1 | 0.1 | NS | |||
| logMAR right eye | 0.1 | 0.1 | NS | |||
| Follow-up | Improved to pre-OP | 7 | 64 | 10 | 91 | NS |
| Deteriorated to pre-OP | 2 | 18 | 1 | 9 | NS | |
| Lost to follow-up | 10 | 38 | 2 | 7 | 0.008 | |
| logMAR left eye | 0 | 0 | 0.1 | NS | ||
| logMAR right eye | 0.05 | 0 | NS | |||
| Visual field | ||||||
| Pre-OP | Impairment (eyes) | 16 | 62 | 15 | 54 | NS |
| Visual field score left eye | 5 | 5,5 | NS | |||
| Visual field score right eye | 4 | 4 | NS | |||
| Post-OP | Improved to pre-OP | 2 | 8 | 10 | 36 | 0.02 |
| Deteriorated to pre-OP | 2 | 8 | 0 | 0 | NS | |
| Lost to follow-up | 2 | 8 | 0 | 0 | NS | |
| Visual field score left eye | 4,5 | 6 | 0.01 | |||
| Visual field score right eye | 4 | 6 | 0.06 | |||
| Follow-up | Improved to pre-OP | 5 | 31 | 13 | 50 | NS |
| Deteriorated to pre-OP | 2 | 12 | 0 | 0 | 0.14 | |
| Lost to follow-up | 10 | 38 | 2 | 7 | 0.008 | |
| Visual field score left eye | 6 | 6 | NS | |||
| Visual field score right eye | 6 | 6 | NS | |||
Visual and pituitary outcome as well as body mass index of patients with a transcranial or endonasal approach to suprasellar craniopharyngiomas prior to surgery compared with postoperative and the follow-up. p ≤ 0.05 is considered statistically significant. NS nonsignificant
| Visual acuity | Visual field deficits | Body mass index | Pituitary function (impaired axes) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| logMAR left | logMAR right | VFD-score left | VFD-score right | Adreno | Thyreo | Somato | Gonado | Diab. Ins. | |||
| Transcranial | Pre-OP | 0.1 | 0.1 | 5 | 4 | 24.6 | 6 | 7 | 3 | 5 | 2 |
| Post-OP | 0.1 | 0.1 | 4.5 | 4 | 12 | 12 | 9 | 11 | 8 | ||
| Follow-up | 0 | 0.05 | 6 | 6 | 35.1 | 9 | 9 | 10 | 10 | 8 | |
| NS | NS | NS | NS | 0.005 | 0.01 | 0.01 | 0.02 | 0.01 | |||
| NS | NS | 0.15 | NS | 0.008 | 0.07 | 0.08 | 0.0004 | 0.003 | 0.003 | ||
| Endonasal | Pre-OP | 0.1 | 0.2 | 5,5 | 4 | 26.5 | 4 | 6 | 8 | 7 | 4 |
| Post-OP | 0.1 | 0.1 | 6 | 6 | 11 | 9 | 11 | 10 | 9 | ||
| Follow-up | 0.1 | 0 | 6 | 6 | 29.8 | 9 | 5 | 12 | 11 | 7 | |
| NS | NS | 0.04 | 0.12 | 0.04 | NS | NS | NS | 0.12 | |||
| NS | 0.01 | 0.01 | 0.03 | 0.14 | 0.03 | NS | 0.06 | 0.07 | 0.15 | ||
Pituitary outcome of patients with a transcranial or endonasal approach to suprasellar craniopharyngiomas. p ≤ 0.05 is considered statistically significant. NS nonsignificant
| Group transcranial | Group endonasal | |||||
|---|---|---|---|---|---|---|
| % | ||||||
| Preoperative | Adrenocorticotrope | 6 | 46 | 4 | 24 | NS |
| Thyreotrope | 7 | 54 | 6 | 35 | NS | |
| Somatotrope | 3 | 23 | 8 | 47 | NS | |
| Gonadotrope | 5 | 38 | 7 | 41 | NS | |
| Diabetes insipidus | 2 | 15 | 4 | 24 | NS | |
| Postoperative | Adrenocorticotrope | 12 | 92 | 11 | 65 | 0.1 |
| Thyreotrope | 12 | 92 | 9 | 53 | 0.04 | |
| Somatotrope | 9 | 69 | 11 | 65 | NS | |
| Gonadotrope | 11 | 85 | 10 | 59 | NS | |
| Diabetes insipidus | 8 | 62 | 9 | 53 | NS | |
| Lost to follow-up | 1 | 7 | 0 | 0 | NS | |
| Long-term follow-up | Adrenocorticotrope | 9 | 69 | 9 | 53 | NS |
| Thyreotrope | 9 | 69 | 5 | 29 | 0.06 | |
| Somatotrope | 10 | 77 | 12 | 71 | NS | |
| Gonadotrope | 10 | 77 | 11 | 65 | NS | |
| Diabetes insipidus | 8 | 62 | 7 | 41 | NS | |
| Lost to follow-up | 3 | 23 | 3 | 18 | NS | |
Quality of life of patients with a transcranial or endonasal approach to suprasellar craniopharyngiomas. p ≤ 0.05 is considered statistically significant. NS nonsignificant
| Group T | Group E | |||
|---|---|---|---|---|
| Long-term follow-up | ||||
| Working status | Full-time worker | 2 | 7 | 0.1 |
| ASBQ | (Median score) | 3.9 | 4.6 | 0.14 |
| SNOT-22 | (Median score) | 17 | 7 | NS |
| Body mass index | (Mean) | 35.1 | 29.8 | 0.05 |
| Olfaction | Left side | 7 | 9 | NS |
| Right side | 7 | 8 | NS | |